A Prospective Non-interventional/Observational Patient Cohort Study on the Efficacy of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients.
A Prospective Non-interventional/Observational Patient Cohort Study on the Efficacy of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients.
The aim of the study was to evaluate the safety and efficacy of intranasal fentanyl spray in cancer patients over four weeks, especially during cancer-related breakthrough pain (BTP) attacks. The fentanyl spray was applied into the nose by a metered-spray device. The study was to provide further data on pharmacoeconomic efficiency of intranasal fentanyl spray.
Inclusion criteria:
Exclusion criteria:
Albstadt-Ebingen, 72458, Germany
Brandenburg/Havel, 14776, Germany
Burg/Fehmarn, 23769, Germany
Großheirath-Rossach, 96269, Germany
Hainburg, 63512, Germany
Hohberg-Hofweiler, 77749, Germany
Karlsbad, 76307, Germany
Kevelaar, 47625, Germany
Lage/Lippe, 32791, Germany
Potsdam-Babelsberg, 14482, Germany
Pulheim-Stommeln, 50259, Germany